Published in Otol Neurotol on March 01, 2016
Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: what we think we know and what we know that we don't know. Bone (2010) 1.59
Third-generation bisphosphonates for treatment of sensorineural hearing loss in otosclerosis. Otol Neurotol (2012) 1.53
Novel actions of bisphosphonates in bone: preservation of osteoblast and osteocyte viability. Bone (2010) 1.41
Volume flow rate of perilymph in the guinea-pig cochlea. Hear Res (1988) 1.40
Bisphosphonate-associated adverse events. Hormones (Athens) (2009) 1.36
Pathophysiology of otosclerosis. Otol Neurotol (2001) 1.23
Fluorescently labeled risedronate and related analogues: "magic linker" synthesis. Bioconjug Chem (2008) 1.22
Perilymph/modiolar communication routes in the human cochlea. Ear Hear (2006) 1.06
Communication between the perilymphatic scalae and spiral ligament visualized by in vivo MRI. Audiol Neurootol (2005) 1.03
Radial communication between the perilymphatic scalae of the cochlea. II: Estimation by bolus injection of tracer into the sealed cochlea. Hear Res (1991) 1.02
Volumetric and dimensional analysis of the guinea pig inner ear. Ann Otol Rhinol Laryngol (2001) 1.02
Marker entry into vestibular perilymph via the stapes following applications to the round window niche of guinea pigs. Hear Res (2011) 0.96
Spiral ligament and stria vascularis changes in cochlear otosclerosis: effect on hearing level. Otol Neurotol (2004) 0.95
Synthesis and characterization of novel fluorescent nitrogen-containing bisphosphonate imaging probes for bone active drugs. Phosphorus Sulfur Silicon Relat Elem (2011) 0.91
Strategies for drug delivery to the human inner ear by multifunctional nanoparticles. Nanomedicine (Lond) (2011) 0.90
Morphometric comparison of endolymphatic and perilymphatic spaces in human temporal bones. Acta Otolaryngol (1986) 0.87
Perilymph Kinetics of FITC-Dextran Reveals Homeostasis Dominated by the Cochlear Aqueduct and Cerebrospinal Fluid. J Assoc Res Otolaryngol (2015) 0.85
Technical report: modification of a cochlear implant electrode for drug delivery to the inner ear. Otol Neurotol (2003) 0.85
Non-Ototoxic Local Delivery of Bisphosphonate to the Mammalian Cochlea. Otol Neurotol (2015) 0.85
Cochlear implantation outcomes in patients with far advanced otosclerosis. Am J Otolaryngol (2012) 0.83
Cochlear implantation in otosclerotic deafness. Adv Otorhinolaryngol (2007) 0.80
Microstructures of the bony modiolus in the human cochlea: a scanning electron microscopic study. J Electron Microsc (Tokyo) (1991) 0.79
Decisive criteria between stapedotomy and cochlear implantation in patients with far advanced otosclerosis. Otol Neurotol (2015) 0.78
Middle-ear endoscopy and trans-tympanic drug delivery using an interventional sialendoscope: feasibility study in human cadaveric temporal bones. J Laryngol Otol (2010) 0.78
Synthesis, biological evaluation, and quantitative structure-activity relationship analysis of new Schiff bases of hydroxysemicarbazide as potential antitumor agents. J Med Chem (2002) 7.27
Correlation of computed tomography with histopathology in otosclerosis. Otol Neurotol (2013) 2.85
Superior semicircular canal dehiscence presenting as conductive hearing loss without vertigo. Otol Neurotol (2004) 2.15
The relationship between the chemistry and biological activity of the bisphosphonates. Bone (2011) 1.86
Pleiotropic role for MYCN in medulloblastoma. Genes Dev (2010) 1.84
Influence of bone affinity on the skeletal distribution of fluorescently labeled bisphosphonates in vivo. J Bone Miner Res (2012) 1.66
Drug delivery for treatment of inner ear disease: current state of knowledge. Ear Hear (2010) 1.65
DNA polymerase beta fidelity: halomethylene-modified leaving groups in pre-steady-state kinetic analysis reveal differences at the chemical transition state. Biochemistry (2007) 1.61
Modifying the beta,gamma leaving-group bridging oxygen alters nucleotide incorporation efficiency, fidelity, and the catalytic mechanism of DNA polymerase beta. Biochemistry (2007) 1.61
Osteoprotegerin in the inner ear may inhibit bone remodeling in the otic capsule. Laryngoscope (2005) 1.53
Third-generation bisphosphonates for treatment of sensorineural hearing loss in otosclerosis. Otol Neurotol (2012) 1.53
Inner ear drug delivery for auditory applications. Adv Drug Deliv Rev (2008) 1.51
Electrocardiographic predictors of electroanatomic scar size in arrhythmogenic right ventricular cardiomyopathy: implications for arrhythmic risk stratification. J Cardiovasc Electrophysiol (2013) 1.49
Inner ear drug delivery via a reciprocating perfusion system in the guinea pig. J Control Release (2005) 1.47
Zebrafish Foxd3 is required for development of a subset of neural crest derivatives. Dev Biol (2005) 1.46
The sense of mastery as a mediator and moderator in the association between economic hardship and health in late life. J Aging Health (2005) 1.42
Fluorescent risedronate analogues reveal bisphosphonate uptake by bone marrow monocytes and localization around osteocytes in vivo. J Bone Miner Res (2010) 1.39
PPARγ-mediated increase in glucose availability sustains chronic Brucella abortus infection in alternatively activated macrophages. Cell Host Microbe (2013) 1.38
Carcinoid tumor of the middle ear: clinical features, recurrences, and metastases. Laryngoscope (2005) 1.35
Alpha,beta-difluoromethylene deoxynucleoside 5'-triphosphates: a convenient synthesis of useful probes for DNA polymerase beta structure and function. Org Lett (2009) 1.34
Median arcuate ligament syndrome: vascular surgical therapy and follow-up of 18 patients. Langenbecks Arch Surg (2009) 1.33
Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patients. Otol Neurotol (2012) 1.33
Operative management of superior semicircular canal dehiscence. Laryngoscope (2005) 1.29
Fluorescently labeled risedronate and related analogues: "magic linker" synthesis. Bioconjug Chem (2008) 1.22
Halogenated beta,gamma-methylene- and ethylidene-dGTP-DNA ternary complexes with DNA polymerase beta: structural evidence for stereospecific binding of the fluoromethylene analogues. J Am Chem Soc (2010) 1.21
The high resolution crystal structure of the human tumor suppressor maspin reveals a novel conformational switch in the G-helix. J Biol Chem (2005) 1.21
RAB26 and RAB3D are direct transcriptional targets of MIST1 that regulate exocrine granule maturation. Mol Cell Biol (2009) 1.19
Erlotinib for progressive vestibular schwannoma in neurofibromatosis 2 patients. Otol Neurotol (2010) 1.19
Exercise limitation following transplantation. Compr Physiol (2012) 1.19
Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers. EMBO Mol Med (2013) 1.16
Postauricular periosteal-pericranial flap for mastoid obliteration and canal wall down tympanomastoidectomy. Otol Neurotol (2004) 1.13
A single DH gene segment creates its own unique CDR-H3 repertoire and is sufficient for B cell development and immune function. J Immunol (2005) 1.13
Primary glia expressing the G93A-SOD1 mutation present a neuroinflammatory phenotype and provide a cellular system for studies of glial inflammation. J Neuroinflammation (2006) 1.11
Chemotherapy-induced apoptosis in a transgenic model of neuroblastoma proceeds through p53 induction. Neoplasia (2008) 1.11
Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma. J Neurooncol (2009) 1.10
Binary complex crystal structure of DNA polymerase β reveals multiple conformations of the templating 8-oxoguanine lesion. Proc Natl Acad Sci U S A (2011) 1.09
Auditory sensitivity regulation via rapid changes in expression of surface AMPA receptors. Nat Neurosci (2007) 1.08
Osteoprotegrin knockout mice demonstrate abnormal remodeling of the otic capsule and progressive hearing loss. Laryngoscope (2006) 1.08
Serine peptide phosphoester prodrugs of cyclic cidofovir: synthesis, transport, and antiviral activity. Mol Pharm (2008) 1.06
A method for intracochlear drug delivery in the mouse. J Neurosci Methods (2005) 1.06
Fatigue depresses maximal in vitro skeletal muscle Na(+)-K(+)-ATPase activity in untrained and trained individuals. J Appl Physiol (1985) (2002) 1.03
A comparative dose-related response of several key pro- and antiinflammatory mediators in the lungs of rats, mice, and hamsters after subchronic inhalation of carbon black. J Occup Environ Med (2006) 1.03
Prolonged exercise to fatigue in humans impairs skeletal muscle Na+-K+-ATPase activity, sarcoplasmic reticulum Ca2+ release, and Ca2+ uptake. J Appl Physiol (1985) (2004) 1.02
High-throughput behavioral screening method for detecting auditory response defects in zebrafish. J Neurosci Methods (2002) 1.02
Prodrug approaches to improving the oral absorption of antiviral nucleotide analogues. Expert Opin Drug Deliv (2009) 1.02
Design and interpretation of anthropometric and fitness testing of basketball players. Sports Med (2008) 1.02
Management outcomes following lateral temporal bone resection for ear and temporal bone malignancies. Otolaryngol Head Neck Surg (2007) 1.02
Exercise performance falls over time in patients with chronic kidney disease despite maintenance of hemoglobin concentration. Clin J Am Soc Nephrol (2006) 1.01
Biphasic requirement for geranylgeraniol in hippocampal long-term potentiation. Proc Natl Acad Sci U S A (2008) 1.00
Peroxisome proliferator-activated receptor delta limits the expansion of pathogenic Th cells during central nervous system autoimmunity. J Exp Med (2010) 0.99
Regulated expression of surface AMPA receptors reduces excitotoxicity in auditory neurons. J Neurophysiol (2009) 0.98
Increased inflammatory cytokine expression in the vastus lateralis of patients with knee osteoarthritis. Arthritis Rheum (2011) 0.98
Superior semicircular canal dehiscence mimicking otosclerotic hearing loss. Adv Otorhinolaryngol (2007) 0.98
Development of a microfluidics-based intracochlear drug delivery device. Audiol Neurootol (2009) 0.96
Phosphonocarboxylates inhibit the second geranylgeranyl addition by Rab geranylgeranyl transferase. J Biol Chem (2008) 0.96
Calpain-3 is autolyzed and hence activated in human skeletal muscle 24 h following a single bout of eccentric exercise. J Appl Physiol (1985) (2007) 0.96
Synthesis and biological activation of an ethylene glycol-linked amino acid conjugate of cyclic cidofovir. Bioorg Med Chem Lett (2006) 0.95
Effect of sodium bicarbonate on muscle metabolism during intense endurance cycling. Med Sci Sports Exerc (2002) 0.94
Proteomics analysis of perilymph and cerebrospinal fluid in mouse. Laryngoscope (2009) 0.94
Training leading to repetition failure enhances bench press strength gains in elite junior athletes. J Strength Cond Res (2005) 0.93
GMP-compliant isolation and expansion of bone marrow-derived MSCs in the closed, automated device quantum cell expansion system. Cell Transplant (2012) 0.93
β,γ-CHF- and β,γ-CHCl-dGTP diastereomers: synthesis, discrete 31P NMR signatures, and absolute configurations of new stereochemical probes for DNA polymerases. J Am Chem Soc (2012) 0.92
Partner smoking characteristics: Associations with smoking and quitting among blue-collar apprentices. Am J Ind Med (2010) 0.92
Surgical excision of acoustic neuroma: patient outcome and provider caseload. Laryngoscope (2003) 0.92
Stereospecific formation of a ternary complex of (S)-α,β-fluoromethylene-dATP with DNA pol β. Chembiochem (2012) 0.92
Transition state in DNA polymerase β catalysis: rate-limiting chemistry altered by base-pair configuration. Biochemistry (2014) 0.91
Synthesis and characterization of novel fluorescent nitrogen-containing bisphosphonate imaging probes for bone active drugs. Phosphorus Sulfur Silicon Relat Elem (2011) 0.91
Sporadic vestibular schwannomas associated with good hearing secrete higher levels of fibroblast growth factor 2 than those associated with poor hearing irrespective of tumor size. Otol Neurotol (2013) 0.91
Validation of an optical encoder during free weight resistance movements and analysis of bench press sticking point power during fatigue. J Strength Cond Res (2007) 0.91
1-(Alpha-aminobenzyl)-2-naphthol: a new chiral auxiliary for the synthesis of enantiopure alpha-aminophosphonic acids. Chemistry (2009) 0.91
Host modulators of H1N1 cytopathogenicity. PLoS One (2012) 0.91
Performance and physiological responses to repeated-sprint exercise: a novel multiple-set approach. Eur J Appl Physiol (2010) 0.91
Fabrication Methods and Performance of Low-Permeability Microfluidic Components for a Miniaturized Wearable Drug Delivery System. J Microelectromech Syst (2009) 0.91
Effects of live high, train low hypoxic exposure on lactate metabolism in trained humans. J Appl Physiol (1985) (2003) 0.90
Retrotransposon profiling of RNA polymerase III initiation sites. Genome Res (2012) 0.90
Synthesis and biological evaluation of alpha-halogenated bisphosphonate and phosphonocarboxylate analogues of risedronate. J Med Chem (2007) 0.90
Bisphosphonate binding affinity affects drug distribution in both intracortical and trabecular bone of rabbits. Calcif Tissue Int (2012) 0.90
α-Azido bisphosphonates: synthesis and nucleotide analogues. J Org Chem (2011) 0.90
Mastoid cavity dimensions and shape: method of measurement and virtual fitting of implantable devices. Audiol Neurootol (2009) 0.89
High-intensity training improves plasma glucose and acid-base regulation during intermittent maximal exercise in type 1 diabetes. Diabetes Care (2007) 0.89
Synthesis and biological evaluation of fluorinated deoxynucleotide analogs based on bis-(difluoromethylene)triphosphoric acid. Proc Natl Acad Sci U S A (2010) 0.89
Activation of skeletal muscle calpain-3 by eccentric exercise in humans does not result in its translocation to the nucleus or cytosol. J Appl Physiol (1985) (2011) 0.89
CD4+ T cell-derived IL-10 promotes Brucella abortus persistence via modulation of macrophage function. PLoS Pathog (2013) 0.89
Effect of β,γ-CHF- and β,γ-CHCl-dGTP halogen atom stereochemistry on the transition state of DNA polymerase β. Biochemistry (2012) 0.88
Dexamethasone up-regulates skeletal muscle maximal Na+,K+ pump activity by muscle group specific mechanisms in humans. J Physiol (2005) 0.88
Clinical factors associated with prolonged recovery after superior canal dehiscence surgery. Otol Neurotol (2012) 0.88
Serine side chain-linked peptidomimetic conjugates of cyclic HPMPC and HPMPA: synthesis and interaction with hPEPT1. Mol Pharm (2010) 0.88
Differences in gene expression between the otic capsule and other bones. Hear Res (2010) 0.88
Facial nerve hemangiomas: vascular tumors or malformations? Otolaryngol Head Neck Surg (2010) 0.88
Effects of fatigue and training on sarcoplasmic reticulum Ca(2+) regulation in human skeletal muscle. J Appl Physiol (1985) (2002) 0.87
A computational study of the hydrolysis of dGTP analogues with halomethylene-modified leaving groups in solution: implications for the mechanism of DNA polymerases. Biochemistry (2009) 0.86